Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitors.
about
Multi-Target Directed Donepezil-Like Ligands for Alzheimer's DiseaseMonoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target DrugsRecent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease.Novel N-allyl/propargyl tetrahydroquinolines: Synthesis via Three-component Cationic Imino Diels-Alder Reaction, Binding Prediction, and Evaluation as Cholinesterase Inhibitors.Monoamine oxidase A and B substrates: probing the pathway for drug development.Propargylamine as functional moiety in the design of multifunctional drugs for neurodegenerative disorders: MAO inhibition and beyond.Catecholamine-Based Treatment in AD Patients: Expectations and Delusions.Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's disease.Recent progress in repositioning Alzheimer's disease drugs based on a multitarget strategy.Protective effect of the multitarget compound DPH-4 on human SSAO/VAP-1-expressing hCMEC/D3 cells under oxygen-glucose deprivation conditions: an in vitro experimental model of cerebral ischaemia.Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics.Anchorage of Au3+ into Modified Isoreticular Metal-Organic Framework-3 as a Heterogeneous Catalyst for the Synthesis of Propargylamines.N-(furan-2-ylmethyl)-N-methylprop-2-yn-1-amine (F2MPA): A potential cognitive enhancer with MAO inhibitor properties.Cross-Dehydrogenative Coupling of Tertiary Amines and Terminal Alkynes Catalyzed by Copper Nanoparticles on Zeolite
P2860
Q26744105-80E1BA17-D3BA-4E13-8A2E-97D4E0B7E462Q28074736-E967E9A2-9035-41DD-B4E0-6C40554FCECFQ35617556-FBA301DA-DA20-4585-8E10-A6C3BAE7B9F2Q37316556-9CB6E847-D292-4322-95BB-8623D18DC664Q38217505-91A283F4-EBB5-427C-B053-B22F624861BBQ38447289-A5B20AF3-D105-422C-BAE2-0F77BDECDFA4Q38497202-8DA8FAC7-ECB4-42E9-8024-73AF36480D88Q38683819-F1D46A92-8F3A-497D-856C-46215D9B620AQ38806779-AF4BD2CF-B2BC-4423-B730-FEF868E4ADD9Q38835918-AB6F46DA-965B-4ABC-9971-BAEFDAB156FAQ38881147-BDC3F7D9-CC7F-4914-9A4E-8010BD799A10Q42371003-387E06D6-8F25-4401-A3E9-412F51044C69Q51733605-661AC0C5-B5ED-454F-A9E0-0EE553C1C423Q57832582-8D8326D1-CA71-4150-91F5-7BD3A0B7BE49
P2860
Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Propargylamine-derived multita ...... monoamine oxidase inhibitors.
@en
type
label
Propargylamine-derived multita ...... monoamine oxidase inhibitors.
@en
prefLabel
Propargylamine-derived multita ...... monoamine oxidase inhibitors.
@en
P2860
P50
P1476
Propargylamine-derived multita ...... monoamine oxidase inhibitors.
@en
P2860
P2888
P304
P356
10.1007/S00702-012-0948-Y
P577
2012-12-13T00:00:00Z